$1.5M sweet spot round size
Most of their 100 investments are in rounds between $28M and $77M
2006
Carmot Therapeutics, Inc. raised $150M on May 25, 2023
Investors: Willett Advisors LLC, TCG X, Millennium Partners, RA Capital Management, L.P. and The Column Group
Synthekine raised $100M on January 6, 2023
Investors: The Column Group
Cajal Neuroscience raised $96M on November 29, 2022
Investors: Lux Capital, Bristol-Myers Squibb, UK, Two Sigma Ventures, Dolby Family Ventures, Evotec and The Column Group
Escient Pharmaceuticals raised $120M on November 28, 2022
Investors: Osage University Partners (OUP), Redmile Group, Sanofi Ventures, Avego Healthcare Capital, The Eleven Fund, Partner Fund Management and The Column Group
Casma Therapeutics raised $46M on November 15, 2022
Investors: Eventide Management Partners, Schroders Capital, Astellas Venture Capital L.L.C., Eisai Asia, Mirae Asset MAPS Global Investments Co., Ltd, Third Rock Ventures and The Column Group
Hexagon Medical International raised $77M on October 11, 2022
Investors: Nextech Invest, 8VC, Two Sigma Ventures and The Column Group
Carmot Therapeutics, Inc. raised $160M on July 26, 2022
Investors: Willett Advisors LLC, Horizons Ventures, RA Capital Management, L.P. and The Column Group
Carmot Therapeutics, Inc. raised $160M on July 26, 2022
Investors: Horizons Ventures, RA Capital Management, L.P., Willett Advisors LLC and The Column Group
Remix Therapeutics raised $70M on May 17, 2022
Investors: Foresite Capital, Atlas Venture, Surveyor Capital, ARCH Venture Partners, Casdin Capital, LLC and The Column Group
Plexium raised $102M on February 23, 2022
Investors: TCG X, Lux Capital, Surveyor Capital, Pappas Capital, SoftBank Investment Advisers, M Ventures, Neotribe Ventures, RA Capital Management, L.P. and The Column Group